Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.G. Rumi
ERYTHROID DIFFERENTIATION IS SUPPRESSED BY RIBAVIRIN DURING COMBINATION THERAPY WITH PEGYLATED INTERFERON-α2A IN CHRONIC HEPATITIS C: AN IN VITRO AND IN VIVO STUDY
Digestive and Liver Disease
Hepatology
Gastroenterology
Related publications
Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction
Acta Hepatologica Japonica
Hepatology
Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C
Turkish Journal of Gastroenterology
Gastroenterology
The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia
Current Therapeutic Research
Pharmacology
Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin
Arquivos de Gastroenterologia
Gastroenterology
Treatment Response and Tolerability of Pegylated Interferon-Α Plus Ribavirin Combination Therapy in Elderly Patients (≥ 65 Years) With Chronic Hepatitis C in Korea
Hepatitis Monthly
Hepatology
Infectious Diseases
Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
Afro-Egyptian Journal of Infectious and Endemic Diseases
Cognitive Function Does Not Worsen During Pegylated Interferon and Ribavirin Retreatment of Chronic Hepatitis C
Hepatology
Medicine
Hepatology
Acute Pancreatitis Associated With Pegylated Interferon-Alpha-2a Therapy in Chronic Hepatitis C
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology